Inogen stock faces a strategic reset after rental sale
Published on 10/04/2026 at 10:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Inogen stock (ISIN US45780L1044) was last at USD 5.97 on Nasdaq on October 2, 2026, at 4:00 p.m. ET, down 0.17 percent from the prior close. The key development is a strategic divestiture announced by Inogen on September 30, 2026.
Rental unit leaves the portfolio
Inogen signed a definitive agreement to sell its U.S. oxygen rental business to Rotech Healthcare for total estimated cash consideration of up to USD 25 million. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions, while a long-term supply agreement is intended to expand access to Inogen oxygen concentrators.
The divested business generated USD 24.3 million in revenue during the first half of 2026, a decline of 9.8 percent year over year, according to Inogen. Beginning with third-quarter 2026 results, the rental unit is expected to be presented as discontinued operations.
Quarterly loss narrows sequentially
Inogen reported second-quarter 2026 revenue of USD 95.08 million and an adjusted EBITDA result of USD 2.4 million. Revenue was below the USD 95.23 million consensus estimate, while the USD 0.14 adjusted loss per share was better than the expected USD 0.15 loss, according to MarketBeat on October 2, 2026.
The sequential picture also improved in the finance data for Q2 2026: revenue reached USD 95.084 million versus USD 85.109 million in Q1 2026, while net loss narrowed to USD 3.850 million from USD 8.324 million. The divestiture therefore targets business mix and profitability as much as immediate cash proceeds.
Target remains above the market
Markets Insider reported on October 1, 2026, that Needham analyst Michael Matson maintained a Buy rating and a USD 12.00 price target. That target lies 101.0 percent above the USD 5.97 reference price, making execution of the streamlined model the central valuation test.
Stock stays below the long term average
Inogen stock was last at USD 5.97 on Nasdaq on October 2, 2026, with 426,761 shares traded. The 52-week range was USD 5.04 to USD 9.13, while market capitalization stood at USD 161.6 million on the same date.
Inogen stock at a glance
- Company: Inogen, Inc.
- ISIN: US45780L1044
- Ticker: INGN
- Trading venue: Nasdaq
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 5.97
- Market capitalization: USD 161.6 million (as of October 2, 2026)
- 52-week range: USD 5.04-9.13 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Equipment, Supplies and Distribution
